Annual Secretarial Compliance Report for the year ended 31-03-2025
3BBLACKBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
3B BlackBio Dx Ltd submitted its Annual Secretarial Compliance Report for FY2024-25, certifying that it generally complied with SEBI LODR regulations. Two minor non-compliances were flagged: (1) a Rs 2,74,760 fine (incl. GST) from BSE for continuing Smt. Mithla Dubey as Non-Executive Director past age 75 without a fresh special resolution under Reg 17(14) – the company passed the required special resolution at the September 2024 AGM and filed a full waiver request on 05-09-2024, which is still pending approval; (2) a Rs 2,00,600 fine (incl. GST) for non-compliance with the composition of the Nomination and Remuneration Committee under Reg 19(1)/19(2) for the quarter ended September 30, 2024 – the committees were reconstituted on 30-09-2024 and a waiver request was filed on 06-12-2024, also pending. The report confirms compliance with Secretarial Standards, insider trading rules, related party transaction approvals, website disclosures, and that the company has a UK subsidiary, TRUPCR Europe Limited.
Routine annual compliance filing with no material business impact. The two BSE fines (total ~Rs 4.75 lakh) are relatively small and the company has filed waiver applications, but the fact that waiver approvals are still awaited is a minor overhang. No change expected in stock price from this disclosure.